Hormel
HRL
$25.71
+2.23%
Hormel Foods Corporation is a branded food company that produces and markets a wide range of meat, protein, and shelf-stable products, operating primarily in the U.S. retail and foodservice channels. As a market leader with iconic brands like Spam, Jennie-O, Planters, and Skippy, Hormel holds the number one or two market share in many of its categories. The current investor narrative centers on a potential turnaround, driven by a solid earnings beat in late May 2026, margin expansion despite cost pressures, and a strategic pivot toward higher-margin value-added proteins following the divestiture of its volatile whole-bird turkey unit.…
HRL
Hormel
$25.71
Related headlines
Investment Opinion: Should I buy HRL Today?
Rating: Hold. Hormel is a defensive turnaround play with a low forward P/E and strong FCF, but sluggish revenue growth and neutral analyst consensus warrant caution. The average analyst target of $26.875 implies 6.9% upside, consistent with a hold rating.
Supporting Evidence: The forward P/E of 16.1x is a 27% discount to the industry average of 22x, offering value if earnings rebound. Revenue grew 2.6% YoY in Q2, but the trend is decelerating. Gross margin improved to 17.4% from 16.7%, and FCF yield is 5.3%. The dividend yield of 4.85% is attractive, but the payout ratio of 132% is a red flag. The stock has strong short-term momentum (up 20.3% in 3 months) but negative 1-year performance (-13.9%).
Risks & Conditions: The thesis would upgrade to Buy if revenue growth accelerates above 4% and net margins expand above 6%, or if the forward P/E compresses below 14x. It would downgrade to Sell if the dividend is cut or if revenue turns negative. Overall, Hormel appears fairly valued relative to its history and peers, with the forward P/E discount offsetting the trailing premium.
Sign up to view all
HRL 12-Month Price Forecast
Hormel is a neutral pick: the low forward P/E and strong FCF provide a valuation floor, but sluggish revenue growth and a high payout ratio limit upside. The stock's recent momentum is encouraging, but sustained improvement in fundamentals is needed to justify a bullish stance. Key catalysts to watch include Q3 earnings (expected late August 2026) and any updates on the turkey divestiture savings. If revenue growth accelerates above 4% and margins expand, the stance would upgrade to bullish; if the dividend is cut or revenue turns negative, it would downgrade to bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Hormel's 12-month outlook, with a consensus price target around $26.88 and implied upside of +4.5% versus the current price.
Average Target
$26.88
0 analysts
Implied Upside
+4.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$25 - $30
Analyst target range
Hormel is covered by 8 analysts, with a consensus recommendation of 'hold' (mean rating of 2.6 on a 1-5 scale where 1 is strong buy). The average target price is $26.875, implying approximately 6.9% upside from the current price of $25.15. The distribution shows no strong bullish or bearish bias, with most analysts maintaining neutral ratings. Recent actions include JP Morgan downgrading from Overweight to Neutral in April 2026, while Barclays remains Overweight. The consensus leans neutral, reflecting uncertainty about the pace of the turnaround. The target price range spans from a low of $25.00 to a high of $30.00. The high target of $30.00 implies 19.3% upside and likely assumes successful margin expansion, revenue growth acceleration, and multiple expansion. The low target of $25.00 is essentially at the current price, suggesting downside risk is limited but upside catalysts are not yet fully visible. The spread between low and high is $5.00, or 20% of the current price, indicating moderate uncertainty. The recent ratings have been mostly neutral, with no upgrades or downgrades in the past month, suggesting analysts are in a wait-and-see mode. The lack of strong conviction from the analyst community means the stock may be more driven by earnings results and macro factors than by analyst sentiment.
Bulls vs Bears: HRL Investment Factors
Hormel presents a mixed picture: the recent earnings beat, margin improvement, and strategic divestiture are encouraging signs of a turnaround, while the low forward P/E and strong FCF offer value. However, sluggish revenue growth, a premium trailing P/E, and neutral analyst sentiment temper enthusiasm. The bull case hinges on sustained margin expansion and revenue acceleration, while the bear case centers on continued top-line weakness and potential dividend risk. Currently, the evidence slightly favors the bull case given the valuation discount and operational improvements, but the stock remains a show-me story.
Bullish
- Earnings Beat Signals Turnaround: Hormel's Q2 2026 earnings beat expectations, with EPS of $0.29 vs. estimates, and the stock surged 13% on May 28, 2026. This positive surprise, combined with a reaffirmed full-year outlook, suggests the company's strategic pivot is gaining traction.
- Margin Expansion Despite Cost Pressures: Gross margin improved to 17.4% in Q2 2026 from 16.7% a year ago, indicating better cost management or pricing power. Operating margin, while down YoY, sequentially improved from 8.0% in Q1 to 7.3% in Q2, suggesting stabilization.
- Attractive Forward Valuation: The forward P/E of 16.1x is at a 27% discount to the packaged foods industry average of 22x, implying the market expects a strong earnings rebound. This low multiple provides a margin of safety if the turnaround materializes.
- Strong Free Cash Flow and Dividend: Trailing twelve-month free cash flow is $693 million, yielding 5.3% on the current market cap. The dividend yield of 4.85% is well-covered by FCF, offering a compelling income stream for defensive investors.
Bearish
- Revenue Growth Remains Sluggish: Q2 2026 revenue grew only 2.6% YoY, and the multi-quarter trend shows deceleration. Q4 2025 revenue actually declined YoY, indicating that top-line momentum is weak despite the earnings beat.
- Trailing P/E Premium to Peers: The trailing P/E of 27.3x is a 24% premium to the industry average of 22x, suggesting the stock is not cheap on past earnings. This premium could compress if the expected earnings rebound fails to materialize.
- Analyst Consensus is Neutral: With a mean rating of 2.6 (hold) and an average target of $26.875 (only 6.9% upside), analysts lack conviction. Recent downgrades, including JP Morgan's move to Neutral, reflect uncertainty about the turnaround pace.
- Net Margin Declining Year-over-Year: Net margin fell to 5.3% in Q2 2026 from 6.2% in Q2 2025, despite gross margin improvement. Higher operating expenses or interest costs are eating into profitability, limiting earnings growth.
HRL Technical Analysis
Hormel's stock is in a recovery phase after a prolonged downtrend, with a 1-year price change of -13.9% reflecting significant underperformance. The current price of $25.15 sits at 62% of its 52-week range ($19.70–$30.09), indicating it has rebounded from the lows but remains well below the highs. This positioning suggests the stock is in a recovery phase but has not yet regained full momentum, offering a potential value opportunity if the turnaround continues. The stock's beta of 0.328 implies it is significantly less volatile than the market, which may appeal to risk-averse investors but also limits upside participation in broad rallies. Short-term momentum is strongly positive, with a 1-month price change of +2.3% and a 3-month change of +20.3%, indicating accelerating momentum. This contrasts sharply with the 1-year decline of -13.9%, suggesting a potential trend reversal or mean reversion. The 3-month relative strength versus SPY is +14.0%, confirming that Hormel has been outperforming the market recently. The 1-month relative strength of +1.7% is modest but positive, indicating continued near-term buying pressure. The 52-week low of $19.70 serves as key support, while the 52-week high of $30.09 is the primary resistance level. A breakout above $30.09 would signal a strong reversal and potential new uptrend, while a breakdown below $19.70 would indicate further downside risk. With a beta of 0.328, Hormel is about 67% less volatile than the S&P 500, meaning it tends to decline less in market selloffs but also rallies less in up markets, which is important for position sizing and risk management.
Beta
0.33
0.33x market volatility
Max Drawdown
-37.4%
Largest decline past year
52-Week Range
$20-$30
Price range past year
Annual Return
-14.0%
Cumulative gain past year
| Period | HRL Return | S&P 500 |
|---|---|---|
| 1m | +4.3% | +0.1% |
| 3m | +21.3% | +5.7% |
| 6m | +6.2% | +8.5% |
| 1y | -14.0% | +20.3% |
| ytd | +9.9% | +10.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HRL Fundamental Analysis
Hormel's revenue trajectory shows modest growth, with Q2 2026 revenue of $2,973 million, up 2.6% year-over-year from $2,899 million in Q2 2025. However, the multi-quarter trend reveals deceleration: Q1 2026 revenue of $3,027 million grew only 1.3% from $2,989 million in Q1 2025, and Q4 2025 revenue of $3,186 million was actually down from $3,138 million in Q4 2024. The Retail segment, which accounts for 62% of sales, generated $1,848 million in Q2 2026, while Foodservice contributed $998 million and International $181 million. The modest growth suggests that Hormel is navigating a challenging consumer environment, but the reaffirmed full-year outlook indicates management's confidence in gradual improvement. Hormel is profitable, with Q2 2026 net income of $157 million and a net margin of 5.3%, though this is down from 6.2% in Q2 2025. Gross margin improved to 17.4% in Q2 2026 from 16.7% a year ago, indicating better cost management or pricing power. Operating margin was 7.3% in Q2 2026, down from 8.6% in Q2 2025, but the sequential improvement from Q1 2026's 8.0% suggests margins are stabilizing. The company's profitability is typical for the packaged foods industry, where net margins often range from 5-10%. Hormel's balance sheet is healthy, with a debt-to-equity ratio of 0.36 and a current ratio of 2.47, indicating strong liquidity. Free cash flow (FCF) for the trailing twelve months was $693 million, providing ample coverage for dividends and capex. The FCF yield is approximately 5.3% based on the current market cap of $13.1 billion, which is attractive for a defensive stock. Return on equity (ROE) of 6.1% is modest but reflects the company's conservative leverage and mature industry.
Quarterly Revenue
$3.0B
2026-04
Revenue YoY Growth
+2.5%
YoY Comparison
Gross Margin
17.4%
Latest Quarter
Free Cash Flow
$692940000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HRL Overvalued?
Since Hormel has positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 27.3x, while the forward P/E is 16.1x, implying that the market expects earnings to grow significantly in the next year. The gap between trailing and forward P/E suggests that the market is pricing in a recovery in earnings, which aligns with the recent earnings beat and reaffirmed outlook. Compared to the packaged foods industry average P/E of approximately 22x, Hormel's trailing P/E of 27.3x represents a 24% premium. However, the forward P/E of 16.1x is at a 27% discount to the industry average forward P/E of 22x, indicating that the market expects Hormel's earnings to rebound strongly. This premium/discount dynamic reflects the market's cautious optimism about the turnaround but also the risk that earnings may not materialize as expected. Historically, Hormel's trailing P/E has ranged from about 18x to 36x over the past five years. The current trailing P/E of 27.3x is near the middle of this range, suggesting it is not excessively expensive or cheap. However, the forward P/E of 16.1x is near the lower end of the historical forward P/E range, which typically has been 15-25x. This implies that the current valuation is pricing in a conservative earnings outlook, which could be attractive if the turnaround gains traction.
PE
27.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Hormel's net margin declined from 6.2% to 5.3% YoY, indicating that cost pressures are outpacing pricing power. The payout ratio of 132% is concerning, as it suggests dividends are not fully covered by earnings, though free cash flow of $693 million provides a cushion. Revenue growth is tepid at 2.6% YoY, and the company faces input cost volatility from commodities like turkey and pork, which could pressure margins further. The debt-to-equity ratio of 0.36 is manageable, but interest expense of $19.8 million per quarter is a fixed cost that eats into profits.
Market & Competitive Risks: Hormel's beta of 0.328 makes it less sensitive to market swings, but the stock has underperformed the S&P 500 by 34.8% over the past year, reflecting company-specific headwinds. The packaged foods industry is highly competitive, with private-label brands gaining share. The recent cattle shortage (record beef prices) could benefit Hormel's protein portfolio, but it also raises input costs. Regulatory risks include potential changes to food labeling or agricultural subsidies. The stock's 52-week range of $19.70-$30.09 shows significant volatility, and the current price near the midpoint suggests uncertainty.
Worst-Case Scenario: If the turnaround stalls—revenue growth remains below 2%, margins contract further, or the dividend is cut—the stock could retest its 52-week low of $19.70, representing a 21.7% decline from the current price of $25.15. In a severe recession, consumer spending on branded foods could decline, and the stock might fall to $18.00 (a 28.4% drop), based on historical max drawdown of 37.4%. The bear case target of $25.00 from analysts implies limited downside, but a break below $19.70 would signal a new downtrend.
FAQ
The key risks are: 1) Financial risk: The payout ratio of 132% means dividends exceed earnings, relying on free cash flow. If FCF declines, a dividend cut could occur. 2) Competitive risk: Private-label brands and other packaged food companies (e.g., Kraft Heinz, Conagra) compete aggressively, pressuring market share and pricing. 3) Macro risk: Input cost volatility (turkey, pork, grains) can squeeze margins; the recent cattle shortage is a double-edged sword. 4) Company-specific risk: The turnaround may stall if revenue growth remains below 2% and margins fail to expand. The most severe risk is a dividend cut, which could trigger a sell-off toward the 52-week low of $19.70.
The 12-month forecast is mixed. The base case (50% probability) sees the stock trading between $25 and $28, aligning with the analyst average target of $26.875, assuming modest growth and stable margins. The bull case (25% probability) targets $28-$30, driven by accelerating revenue and margin expansion. The bear case (25% probability) sees the stock falling to $20-$25, with risks of a dividend cut or stalled turnaround. The most likely scenario is the base case, with gradual improvement but no major catalysts. The AI assessment is neutral, with a medium confidence level.
HRL appears fairly valued with a mixed signal. The trailing P/E of 27.3x is a 24% premium to the packaged foods industry average of 22x, suggesting it is overvalued on past earnings. However, the forward P/E of 16.1x is a 27% discount to the industry forward average of 22x, implying the market expects a strong earnings rebound. Historically, HRL's trailing P/E has ranged from 18x to 36x over the past five years, and the current 27.3x is near the middle. The forward P/E of 16.1x is near the lower end of its historical forward range of 15-25x. Overall, the valuation is reasonable if the turnaround succeeds, but expensive if it fails.
HRL is a hold for most investors. The stock offers a high dividend yield of 4.85% and a low forward P/E of 16.1x, which is a 27% discount to the industry average. However, revenue growth is sluggish at 2.6% YoY, and the trailing P/E of 27.3x is a 24% premium to peers. The analyst consensus is neutral with only 6.9% upside to the average target. For income-focused investors with a long-term horizon, HRL could be a good buy at current levels, but growth-oriented investors may find better opportunities elsewhere. The biggest downside risk is a dividend cut if free cash flow deteriorates.
HRL is more suitable for long-term investment, given its low beta of 0.33, high dividend yield of 4.85%, and defensive nature. The stock is less volatile than the market, making it a good portfolio stabilizer. Short-term traders may find limited upside due to the neutral analyst consensus and modest 6.9% target upside. The recent 3-month momentum (+20.3%) suggests short-term gains are possible, but the 1-year decline of -13.9% highlights the risk of mean reversion. A minimum holding period of 2-3 years is recommended to allow the turnaround to play out and to collect dividends. For income-focused investors, HRL can be a core long-term holding.